
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gout – An update of aetiology, genetics, co-morbidities and management
Philip C. Robinson
Maturitas (2018) Vol. 118, pp. 67-73
Closed Access | Times Cited: 84
Philip C. Robinson
Maturitas (2018) Vol. 118, pp. 67-73
Closed Access | Times Cited: 84
Showing 1-25 of 84 citing articles:
Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.
Lijun Li, Yipeng Zhang, Changchun Zeng
PubMed (2020) Vol. 12, Iss. 7, pp. 3167-3181
Closed Access | Times Cited: 164
Lijun Li, Yipeng Zhang, Changchun Zeng
PubMed (2020) Vol. 12, Iss. 7, pp. 3167-3181
Closed Access | Times Cited: 164
Impaired intestinal barrier function in a mouse model of hyperuricemia
Yingjie Guo, Hailong Li, Zhen Liu, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 84
Yingjie Guo, Hailong Li, Zhen Liu, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 84
The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
Robert Eckenstaler, Ralf A. Benndorf
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6678-6678
Open Access | Times Cited: 83
Robert Eckenstaler, Ralf A. Benndorf
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6678-6678
Open Access | Times Cited: 83
Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients
Arrigo F.G. Cicero, Federica Fogacci, Raffaele Ivan Cincione, et al.
Medical Principles and Practice (2020) Vol. 30, Iss. 2, pp. 122-130
Open Access | Times Cited: 77
Arrigo F.G. Cicero, Federica Fogacci, Raffaele Ivan Cincione, et al.
Medical Principles and Practice (2020) Vol. 30, Iss. 2, pp. 122-130
Open Access | Times Cited: 77
A review on gout: Looking back and looking ahead
Haolin Tao, Yingshi Mo, Wenbin Liu, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109977-109977
Closed Access | Times Cited: 30
Haolin Tao, Yingshi Mo, Wenbin Liu, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109977-109977
Closed Access | Times Cited: 30
Agents for the Treatment of Gout: Current Advances and Future Perspectives
Xiaoyi Zeng, Yajing Liu, Yuxin Fan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14474-14493
Closed Access | Times Cited: 24
Xiaoyi Zeng, Yajing Liu, Yuxin Fan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14474-14493
Closed Access | Times Cited: 24
Artesunate improves glucose and lipid metabolism in db/db mice by regulating the metabolic profile and the MAPK/PI3K/Akt signalling pathway
Lulu Chen, Jialin Wang, Yanshuang Ren, et al.
Phytomedicine (2024) Vol. 126, pp. 155382-155382
Closed Access | Times Cited: 16
Lulu Chen, Jialin Wang, Yanshuang Ren, et al.
Phytomedicine (2024) Vol. 126, pp. 155382-155382
Closed Access | Times Cited: 16
<p>Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications</p>
Min Gong, Song Wen, Thiquynhnga Nguyen, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 943-962
Open Access | Times Cited: 66
Min Gong, Song Wen, Thiquynhnga Nguyen, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 943-962
Open Access | Times Cited: 66
Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology
Pei Liu, Huachong Xu, Yucong Shi, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 55
Pei Liu, Huachong Xu, Yucong Shi, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 55
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
Anti-Gout Effects of the Medicinal Fungus Phellinus igniarius in Hyperuricaemia and Acute Gouty Arthritis Rat Models
Hongxing Li, Xinyue Zhang, Lili Gu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 31
Hongxing Li, Xinyue Zhang, Lili Gu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 31
Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009–2014
Franco Scinicariello, Melanie C. Buser, Lina S. Balluz, et al.
Chemosphere (2020) Vol. 259, pp. 127446-127446
Open Access | Times Cited: 45
Franco Scinicariello, Melanie C. Buser, Lina S. Balluz, et al.
Chemosphere (2020) Vol. 259, pp. 127446-127446
Open Access | Times Cited: 45
Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota
Suxian Lin, Tao Zhang, Lingxiao Zhu, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 9, pp. 781-791
Closed Access | Times Cited: 36
Suxian Lin, Tao Zhang, Lingxiao Zhu, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 9, pp. 781-791
Closed Access | Times Cited: 36
Relationship between hyperuricemia with deposition and sexual dysfunction in males and females
Andrea Sansone, Yacov Reisman, Emmanuele A. Jannini
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 4, pp. 691-703
Open Access | Times Cited: 23
Andrea Sansone, Yacov Reisman, Emmanuele A. Jannini
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 4, pp. 691-703
Open Access | Times Cited: 23
Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors
Qing Mao, Xiwen Dai, Gaoyang Xu, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111558-111558
Closed Access | Times Cited: 38
Qing Mao, Xiwen Dai, Gaoyang Xu, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111558-111558
Closed Access | Times Cited: 38
Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats
Xue Chen, Hong-Zhang Ge, Shanshan Lei, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110765-110765
Open Access | Times Cited: 36
Xue Chen, Hong-Zhang Ge, Shanshan Lei, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110765-110765
Open Access | Times Cited: 36
Research on the effect and underlying molecular mechanism of Cangzhu in the treatment of gouty arthritis
Chao Li, Chan Wang, Yijing Guo, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175044-175044
Open Access | Times Cited: 20
Chao Li, Chan Wang, Yijing Guo, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175044-175044
Open Access | Times Cited: 20
NMR-Based Metabonomic Study Reveals Intervention Effects of Polydatin on Potassium Oxonate-Induced Hyperuricemia in Rats
Bin Han, Mengjuan Gong, Li Zhong, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 32
Bin Han, Mengjuan Gong, Li Zhong, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 32
Urate Crystals; Beyond Joints
Muhammad Israr Ahmad, Salman Masood, Daniel Furlanetto, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Muhammad Israr Ahmad, Salman Masood, Daniel Furlanetto, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Network pharmacology and in vivo experiments reveal the pharmacological effects and molecular mechanisms of Simiao Powder in prevention and treatment for gout
Huachong Xu, Jialin Wu, Shiqi Wang, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Huachong Xu, Jialin Wu, Shiqi Wang, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Hyperuricemia insights: Formation, targets and hypouricemic natural products
Wei Zeng, Mohamed Ghamry, Zhiheng Zhao, et al.
Food Bioscience (2025), pp. 105944-105944
Closed Access
Wei Zeng, Mohamed Ghamry, Zhiheng Zhao, et al.
Food Bioscience (2025), pp. 105944-105944
Closed Access
Gouty Tophus in the Small Bowel Mimicking a Calcifying Mesenteric Mass
Vanessa Diller, Daniel Pérez, Alexander Harms, et al.
Cureus (2025)
Open Access
Vanessa Diller, Daniel Pérez, Alexander Harms, et al.
Cureus (2025)
Open Access
Monocyte to Lymphocyte Ratio, Neutrophil to Lymphocyte Ratio, and Red Cell Distribution Width are the Associates with Gouty Arthritis
Cengiz Kadıyoran, Orhan Zengin, Hilal Akay Çizmecioğlu, et al.
Acta Medica (Hradec Kralove Czech Republic) (2019) Vol. 62, Iss. 3, pp. 99-104
Open Access | Times Cited: 29
Cengiz Kadıyoran, Orhan Zengin, Hilal Akay Çizmecioğlu, et al.
Acta Medica (Hradec Kralove Czech Republic) (2019) Vol. 62, Iss. 3, pp. 99-104
Open Access | Times Cited: 29
The dose-response relationship between sex hormones and hyperuricemia in different gender: NHANES 2013-2016
Guoyun Li, Xu-dong Qian, Chun‐Ming Ma, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 15
Guoyun Li, Xu-dong Qian, Chun‐Ming Ma, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 15
Exploring the role of gut microbiota dysbiosis in gout pathogenesis: a systematic review
Salman Shirvani-Rad, Niloufar Khatibzade‐Nasari, Hanieh‐Sadat Ejtahed, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9
Salman Shirvani-Rad, Niloufar Khatibzade‐Nasari, Hanieh‐Sadat Ejtahed, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9